INTERIM ANALYSIS OF A PHASE-III STUDY ON PREOPERATIVE RADIATION-THERAPY IN RESECTABLE RECTAL-CARCINOMA - TRIAL OF THE GASTROINTESTINAL-TRACT CANCER COOPERATIVE GROUP OF THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-ON-TREATMENT-OF-CANCER (EORTC)

被引：0
|
作者：
GERARD, A
BERROD, JL
PENE, F
LOYGUE, J
LAUGIER, A
BRUCKNER, R
CAMELOT, G
ARNAUD, JP
METZGER, U
BUYSE, M
DALESIO, O
DUEZ, N
机构：
[1] HOP ST ANTOINE, F-75571 PARIS 12, FRANCE
[2] HOP TENON, F-75970 PARIS 20, FRANCE
[3] UNIV MAINZ KLINIKEN, MAINZ, FED REP GER
[4] UNIV HOSP BESANCON, BESANCON, FRANCE
[5] CTR MED CHIRURG, STRASBOURG, FRANCE
[6] UNIV HOSP ZURICH, CH-8091 ZURICH, SWITZERLAND
[7] EUROPEAN ORG RES TREATMENT CANC DATA CTR, BRUSSELS, BELGIUM
来源：
CANCER | 1985年 / 55卷 / 10期
关键词：
D O I：
10.1002/1097-0142(19850515)55:10<2373::AID-CNCR2820551012>3.0.CO;2-D
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2373 / 2379
页数：7
相关论文
共 42 条
  • [41] Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapya European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)
    Coens, Corneel
    van der Graaf, Winette T. A.
    Blay, Jean-Yves
    Chawla, Sant P.
    Judson, Ian
    Sanfilippo, Roberta
    Manson, Stephanie C.
    Hodge, Rachel A.
    Marreaud, Sandrine
    Prins, Judith B.
    Lugowska, Iwona
    Litiere, Saskia
    Bottomley, Andrew
    CANCER, 2015, 121 (17) : 2933 - 2941
  • [42] Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group
    Le Cesne, A
    Judson, I
    Crowther, D
    Rodenhuis, S
    Keizer, HJ
    Van Hoesel, Q
    Blay, JY
    Frisch, J
    Van Glabbeke, M
    Hermans, C
    Van Oosterom, A
    Tursz, T
    Verweij, J
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) : 2676 - 2684
12345